GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (FRA:XN4) » Definitions » Other Assets for Banks

Big Pharma Split (FRA:XN4) Other Assets for Banks : €17.62 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Big Pharma Split Other Assets for Banks?

Big Pharma Split's quarterly other assets (bank) declined from Jun. 2023 (€19.00 Mil) to Dec. 2023 (€17.95 Mil) and declined from Dec. 2023 (€17.95 Mil) to Jun. 2024 (€17.62 Mil).

Big Pharma Split's annual other assets (bank) declined from Dec. 2021 (€25.09 Mil) to Dec. 2022 (€16.87 Mil) but then increased from Dec. 2022 (€16.87 Mil) to Dec. 2023 (€17.95 Mil).

Big Pharma Split Other Assets for Banks Historical Data

The historical data trend for Big Pharma Split's Other Assets for Banks can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split Other Assets for Banks Chart

Big Pharma Split Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Assets for Banks
Get a 7-Day Free Trial 18.16 14.50 25.09 16.87 17.95

Big Pharma Split Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Assets for Banks Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.62 16.87 19.00 17.95 17.62

Big Pharma Split Other Assets for Banks Calculation

Banks frequently group a variety of accounts as other assets on their balance sheets. Banks must report several of these accounts, such as investment in unconsolidated subsidiaries, customer liability on outstanding acceptances, and intangible assets as separate line items on Call Reports.

Big Pharma Split Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (FRA:XN4) » Definitions » Other Assets for Banks
Comparable Companies
TSX:XTD TSXV:MIVO TSXV:CSOC.A NEOE:JPEG XCNQ:SOL TSXV:TORR TSXV:CLCO TSXV:AIVC TSXV:ELC XCNQ:TLP.UN BLK BX KKR OSTO:INVE A TSX:BAM TSX:BN APO LSE:III AMP XSWX:PGHN
Traded in Other Exchanges
PRM.PR.A.PFD:Canada PRM:Canada
Address
610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Website
https://www.harvestportfolios.com
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.

Big Pharma Split Headlines

No Headlines